Thank you, Marcus. Now let's shift our focus to Slide 11 where I'll update you on our 2023 initiatives. We are forecasting approximately $45 million of negative impact due to declining commodity prices for viscose, fluff, Paper pulp and high-yield pulp. Additionally, the lower-than-expected sales orders due to destocking in construction ethers, MCC and filtration and paper port market sectors have impacted results by approximately $15 million. While we see this inflation in some key raw material inputs, we continue to experience high prices and/or inflationary pressures for some key raw materials, including wood, caustic soda, labor and MRO supplies. In response, our management team is proactively reducing our expenses in the second half by nearly $40 million to largely mitigate these impacts. These mitigation actions include reducing contractor services; reducing overtime in a hiring freeze; lower wood, caustic and freight purchase prices; and improved productivity; and higher power sales prices. Consequently, we can provide an update to the 2023 EBITDA guidance of $185 million to $200 million. That will exceed both prior year results in our current fixed charges. Despite the lower EBITDA outlook, we are raising our guidance for our 2023 free cash flow to $55 million to $70 million. To date, we have generated $52 million of free cash flow primarily from the monetization of working capital. We expect that this will be partially reversed in the back half of the year as we rebuild the depleted inventories at that just have ended [inaudible] meeting following their annual shutdowns. Also, we reduced our forecast for total CapEx spending for the year to $125 million. This includes $30 million of strategic CapEx, which remains discretionary. Flexibility is key right now, and we'll dial back the strategic capital accordingly if needed. We are maintaining our focus on capturing high value for our specialty products, particularly in our Cellular Specialty segment. Notably, our cellulose specialty prices have increased by 13% compared to the prior year period, contributed to the successful contract negotiations for 2023. Moving forward, we will continue to prioritize the value of our cellulose specialties, ensuring a strategic approach to optimize profitability across the cycle. Finally, in response to the severe pricing volatility affecting our commodity products. We have initiated a review of strategic options for our viscose and paper pulp businesses. Our cellulose specialties and pulp businesses are core businesses. And paperboards, a solid EBITDA contributor provides very promising long-term growth potential. In aggregate, these businesses will deliver nearly $300 million of EBITDA in 2023, exclusive of corporate overhead. This is a strong performance given today's challenging environment. Conversely, the viscose and paper pulp businesses will subtract an estimated $50 million of EBITDA due to the current low sales prices with most of these losses concentrated in the North American sulphite mills. We historically used the production and sale of commodity products to maintain high utilization rates at our six high-purity production lines to maximize fixed cost absorption. However, the production and sales of commodity products have masked the strength and profitability of our Cellulose Specialty segment. and, in times like these, only provide marginal financial benefit. Consequently, it's time to reconsider our strategy. So over the course of the next couple of months, we will review our options to mitigate most of these commodity losses in 2024. The potential EBITDA of our core business is significantly greater than the market gives us credit for. And so the strategic review, we'll look to optimize our asset base to reduce cost and minimize exposure to these commodity businesses to ensure the long-term success and sustainable growth of our overall enterprise. Now let's shift our attention to Slide 12, where we'll review our progress against our 2023 guidance for EBITDA and free cash flow. The waterfall chart reinforces our commitment to achieving free cash flow within the $55 million to $70 million range, with EBITDA expected to be $185 million to $200 million for the year. We're also projecting lower cash outflows to more than offset the lower EBITDA, including interest expense, CapEx and other liabilities while increasing working capital monetization targets to achieve our goal. With the refinancing complete, we have a clear line of sight to $65 million of cash interest for the year. This fixed charge is likely to increase next year to about $70 million as we realize the full impact of the higher interest rates. Maintenance CapEx remains at $90 million on a normalized basis, but we are now removing most of the catch-up capital in 2023 as we can sustain our current operating levels without the need for the additional capital spend. With $86 million of working capital benefits captured through the first six months, we expect to retain the majority of those benefits with a $55 million target for the year. Lastly, we are engaged in ongoing discussions with our government partners in France regarding the deferred energy liabilities for which we expect nonpositive outcomes. As previously discussed, our free cash flow will be strategically allocated to either repay debt or invest in attractive strategic projects. On Slide 13, we delve deeper into the expected performance of each of our businesses in the second half of 2023. Cellulose specialty prices are expected to finish the year at a high single-digit percentage increase compared to 2022. However, we anticipate a decrease in sales volumes for cellulose specialties compared to the prior year, driven by weakened demand and significant customer destocking. Market demand for commodity products is expected to remain resilient, albeit at lower prices than those observed in the first half of the year. Notably, fluff prices have declined compared to 2022 levels aligning with industry forecast. And viscose prices are expected to reach a bottom in Q3, followed by a slight uptick in Q4. While certain input costs are moderating, it is important to note that most of these costs continue to remain at elevated levels. As part of our ongoing growth strategy, we are also pursuing strategic investments in our biomaterials business. Exciting progress is being made with the bioethanol plant in Tartas, and we're pleased to report that remains on track for production commencement in early 2024. The second generation ethanol produced at this facility is projected to provide an EBITDA benefit of $8 million to $10 million annually, further bolstering our position as we forge ahead with our long term business of sustainable and profitable growth. We're excited about our biomaterial business plan. Over the next three to five years, the phase of this plan is expected to yield an additional $100 million in revenue and about $42 million of EBITDA annually. We expect most of these projects come with low-cost financing to make them extremely attractive investments. We are also working on the second and third phase of this business plan that would create further sustainable growth. In paperboard, prices are expected to moderate slightly over the balance of the year but remain elevated as compared to 2022 levels. Sales volumes are expected to improve in the second half of the year as destocking eases. As evidenced, we did see orders pick up in July. Raw material prices are expected to reduce further as pulp markets decline. In high-yield pulp, prices are expected to be impacted by both the global economic slowdown and new capacity coming into the market. As a result of these factors, sales volume will decline in Q3 as we take necessary downtime in July and August and in response to prevailing market conditions. We are continuing to operate 1 of our 2 high-yield pulp in our paperboard operations. Corporate expenses are expected to be higher than in 2022, primarily driven by expenses associated with the ERP implementation in the absence of foreign exchange benefits, positively impacted in 2022, specifically in the third quarter of last year and are not expected to repeat this year. As already noted, we are reducing our CapEx guidance to $125 million net of financing, of which $95 million will be earmarked as maintenance CapEx and the remainder strategic CapEx. We have raised the investment hurdle for new strategic capital projects to help mitigate the impact of higher interest rates. Projects now need to generate at least a 30% return on equity and have a 2-year or less payback period. Turning to Slide 14. We picked progression of our EBITDA margin growth and net leverage decline. Throughout the year, we anticipate our margins to remain within the 10% to 11% range, which as noted, is a weighted average of the strong margins we enjoy in the cellulose specialties and paperboard segments and the negative margins expected in the viscose and other commodity businesses. Net leverage is expected to increase to 3.8x for the full year at the midpoint of the lower EBITDA guidance. However, we remain committed to drive toward our target net leverage ratio up to 2.5x over the next three to five years. I'm confident that the second half of 2023 results will be stronger than the first half. Paperboard sales volumes are showing signs of normalizing, and I believe that our businesses that are more GDP sensitive will pick up in the second half. Three of the four scheduled plant outages are now behind us, including the absence of our two largest facilities, thus we will see improved productivity and lower spending. And we will execute on the nearly $40 million in expense reductions in the $10 million to $15 million at CapEx curtailments. Now I'd like to direct your attention to Slide 15 of the presentation materials, where we have an exciting announcement to share with you. We cordially invite you to attend our Investor Day on Tuesday, October 10, 2023 at the New York Stock Exchange. To secure your attendance, kindly RSVP through the e-mail address provided. As the date draws near, we will provide you with the more comprehensive details about the event. We're looking forward to this occasion as it will be fantastic opportunity to connect, discuss our strategic vision and explore future growth plan including details about our biomaterials business plan. Your continued support and engagement mean a lot to us, and we are able to share our insights and progress at our upcoming Investor Day. With that, operator, please open the call to questions.